Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Trospium for CRBD Prevention in ICU
NCT06346522Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gabapentin and trospium in cystitis (3 arms), sponsored by Ain Shams University. Primary endpoints: Incidence of Catheter-related Bladder Discomfort at 24 hours and Severity of Catheter-related Bladder Discomfort at 24 hours. Started Apr 2024; status: completed.
02
Drugs
gabapentintrospium
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT06346522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06346522.